Article | September 6, 2023

How AI And ML Can Transform Clinical Trial Conduct

Source: Medable
GettyImages-1320799464 AI

Undoubtedly, 2023 will be etched in history as the pivotal year for the ascendance of generative artificial intelligence (AI) and machine learning (ML) in both the technology and pharmaceutical sectors. Much like the exponential rise of digital and decentralized trials in 2020, AI and ML are ushering in a transformative era, redefining the boundaries of drug and treatment development.

In light of recent FDA publications outlining a forward-looking framework, sponsors and Contract Research Organizations (CROs) worldwide are fervently exploring ways to fortify their drug development strategies. As these advancements unfold at an unprecedented pace, this article offers an insightful overview of the multifaceted applications of AI and ML in the realm of clinical research, shedding light on their profound impact and potential to revolutionize the industry.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader